Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling

Autor: Peters, Sebastian, Kuespert, Sabrina, Wirkert, Eva, Heydn, Rosmarie, Jurek, Benjamin, Johannesen, Siw, Hsam, Ohnmar, Korte, Sven, Ludwig, Florian Timo, Mecklenburg, Lars, Mrowetz, Heike, Altendorfer, Barbara, Poupardin, Rodolphe, Petri, Susanne, Thal, Dietmar R., Hermann, Andreas, Weishaupt, Jochen H., Weis, Joachim, Aksoylu, Inci Sevval, Lewandowski, Sebastian A., Aigner, Ludwig, Bruun, Tim-Henrik, Bogdahn, Ulrich

Publikováno v: In Neurotherapeutics July 2021 18(3):1963-1979

Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset (Nature Medicine, (2021), 27, 4, (640-646), 10.1038/s41591-021-01295-9)

Autor: Månberg, Anna, Skene, Nathan, Sanders, Folkert, Trusohamn, Marta, Remnestål, Julia, Szczepińska, Anna, Aksoylu, Inci Sevval, Lönnerberg, Peter, Ebarasi, Lwaki, Wouters, Stefan, Lehmann, Manuela, Olofsson, Jennie, von Gohren Antequera, Inti, Domaniku, Aylin, de Schaepdryver, Maxim, de Vocht, Joke, Poesen, Koen, Uhlén, Mathias, Anink, Jasper, Mijnsbergen, Caroline, Vergunst-Bosch, Hermieneke, Hübers, Annemarie, Kläppe, Ulf, Rodriguez-Vieitez, Elena, Gilthorpe, Jonathan D., Hedlund, Eva, Harris, Robert A., Aronica, Eleonora, van Damme, Philip, Ludolph, Albert, Veldink, Jan, Ingre, Caroline, Nilsson, Peter, Lewandowski, Sebastian A.

Publikováno v: Nature medicine, 27(7). Nature Publishing Group

In the version of this article initially published, the label along the right margin of the top row in Fig. 2d (SO1DG93A) was incorrect. The correct label is ‘SOD1G93A’. The error has been corrected in the HTML and PDF versions of the article.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4dca0960aa80e2e7284de5e96775bc04
https://pure.amc.nl/en/publications/publisher-correction-altered-perivascular-fibroblast-activity-precedes-als-disease-onset-nature-medicine-2021-27-4-640646-101038s41591021012959(0d84278b-342e-439c-a810-77cf2a0db5a2).html

Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset.

Autor: Månberg A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden., Skene N; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK.; United Kingdom Dementia Research Institute, London, UK., Sanders F; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., Trusohamn M; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden., Remnestål J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden., Szczepińska A; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., Aksoylu IS; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., Lönnerberg P; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden., Ebarasi L; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Wouters S; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., Lehmann M; Department of Integrative Medical Biology, Umeå University, Umeå, Sweden., Olofsson J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden., von Gohren Antequera I; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., Domaniku A; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., De Schaepdryver M; Laboratory for Neurobiomarker Research, Department of Neurology, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium., De Vocht J; Neurology Department and Center for Brain & Disease Research, KU Leuven, VIB, Leuven, Belgium., Poesen K; Laboratory for Neurobiomarker Research, Department of Neurology, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.; Laboratory Medicine, UZ Leuven (University Hospital Leuven), Leuven, Belgium., Uhlén M; Division of Systems Biology, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Department of Neuroscience, Karolinska Institute, Stockholm, Sweden., Anink J; Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Mijnsbergen C; Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Vergunst-Bosch H; UMC Utrecht Brain Center, University Medical Center Utrecht, Department of Neurology, Utrecht University, Utrecht, the Netherlands., Hübers A; University of Ulm, Neurology Clinic, Ulm, Germany.; Division of Neurology, Geneva University Hospital, Geneva, Switzerland., Kläppe U; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden., Rodriguez-Vieitez E; Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Gilthorpe JD; Department of Integrative Medical Biology, Umeå University, Umeå, Sweden., Hedlund E; Department of Neuroscience, Karolinska Institute, Stockholm, Sweden., Harris RA; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden., Aronica E; Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Van Damme P; Neurology Department and Center for Brain & Disease Research, KU Leuven, VIB, Leuven, Belgium., Ludolph A; University of Ulm, Neurology Clinic, Ulm, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Bonn, Germany., Veldink J; UMC Utrecht Brain Center, University Medical Center Utrecht, Department of Neurology, Utrecht University, Utrecht, the Netherlands., Ingre C; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden., Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden., Lewandowski SA; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden. sebastian.lewandowski@ki.se.; Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. sebastian.lewandowski@ki.se.

Publikováno v: Nature medicine [Nat Med] 2021 Jul; Vol. 27 (7), pp. 1308.